An autologous point-of-care cell therapy for adults with ischemic HF with reduced ejection fraction was safe and may be beneficial for select candidates, though a pivotal study did not meet its ...

In this Healio Video Perspective, M. Francesca Cordeiro, MD, PhD, highlights three hot topics in glaucoma discussed at the Congress on Controversies in Ophthalmology.

Switching to an in-house dialysis model may support health care facilities in care efforts and lead to high quality outcomes for patients, according to study data. Brittni McGill, MSN, RN, NEA-BC, ...

Results of prespecified analyses, presented at the American College of Cardiology Scientific Session, found that tafamidis ...

The FDA announced it will be reducing, refining and potentially replacing the animal testing requirement for the approval of ...

While the percentage of female providers in orthopedics increased from 2018 to 2023, the rate of increase was lower than ...

Results presented here showed focal articular surface replacement may be a viable treatment option for focal articular defects in patients younger than 40 years.“Both [biologics and resurfacing] ...

Crystal L. Mackall, MD, renowned for her “pioneering work in CAR T-cell therapy,” will receive this year’s American ...

A patient navigation program significantly improved the odds that people would get a colonoscopy after receiving an abnormal ...

Research into Sjögren’s disease — both analyzing the condition itself and testing potential treatments — has come a long way ...

Neoadjuvant combination immunotherapy may improve survival compared with single-agent therapy for patients with head and neck squamous cell carcinoma, according to results of a randomized phase 2 ...

More than 3 million children died from antimicrobial resistance-associated complications in 2022 across the globe, most of ...